Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Crisper/ Onc partnership
View:
Post by askretka on Nov 10, 2021 1:02pm

Crisper/ Onc partnership

Anyone else think it was strange that Matt mentioned the CRISPR CAR-T data as promising? The only CAR-T company mentioned, might just be a coincidence or is there more to the story? Got me to thinking what s great partner they would be. They could possibly take a look at Reovirus genetic code as well and see if they could tweak it for the future. One can always dream a little. Cheers!
Comment by inthno on Nov 10, 2021 2:53pm
Think about it in the bigger picture. Everything that Matt talks about is promising, as to when a promise will be fullfilled, well that is a story for another time.
Comment by fox7mf on Nov 11, 2021 10:42am
What's this gonna bleed to before Coffey & Co. decide to release another nugget that fails to inspire any investor confidence? Were analysts perhaps given more info of goings on as to avoid the dreaded downgrade?
Comment by inthno on Nov 11, 2021 11:19am
analysts supposedly do not have access to different information than us but I think that they do have more access to talk to onc than the average shareholders which seem to be shut out for the most part. What I do find surprising is that onc did not give the partnership update that the analysts were asking for and yet held the rating although it has been pushed back...I do find it interesting that ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities